Dermal Laboratories Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk

Summary of Product Characteristics last updated on the eMC: 14/11/2008
SPC Ibugel

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/11/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   01-Oct-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 9 (Renewal of the Authorisation) : the date has changed to "2 September 2007".
Updated on 18/02/2008 and displayed until 14/11/2008
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Date of revision of text on the SPC:   10/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.5 - Interaction with other medicinal products and other forms of interaction: Additional text in bold has been added, as follows: " ... blood pressure lowering drugs, and may possibly enhance the effects of anticoagulants, although the chance of either of these occurring with a topically administered preparation is extremely remote."
Updated on 11/09/2007 and displayed until 18/02/2008
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   09/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5 - Nature and contents of container - Deletion of text 'This is supplied as an original pack (OP)'
Updated on 03/08/2004 and displayed until 11/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 19/06/2003 and displayed until 03/08/2004
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 10 (date of (partial) revision of the text
Updated on 17/09/2002 and displayed until 19/06/2003
Reasons for adding or updating:
  • Change to section 3 - pharmaceutical form
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 10 (date of (partial) revision of the text
Updated on 11/02/2002 and displayed until 17/09/2002
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 01/02/2002 and displayed until 11/02/2002
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 19/07/2001 and displayed until 01/02/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 08/02/2001 and displayed until 19/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 08/02/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ibuprofen